All Posts Tagged With: "UAM"
(CVS) CVS Caremark Remains Neutral
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $46.00.
CVS reported adjusted EPS of 89 cents in the fourth quarter of 2011 in line with the...
(WLP) These Healthcare Insurance Stocks Are Ready to Rise
by Marc Lichtenfeld, Healthcare Expert
Wednesday, February 24, 2010: Issue...
(CVS) CVS Caremark Corporation to Attend Healthcare Conference
The leading provider of prescriptions and related health care services in the US, CVS Caremark Corporation (CVS) has decided to participate in the annual JP Morgan Healthcare Conference scheduled on January...
(CVS) CVS Caremark Launches New Pharmacy Advisor Program
CVS Caremark (CVS) recently launched a new Pharmacy Advisor program to help treat chronic cardiovascular illness.
The Pharmacy Advisor for chronic cardiovascular care will primarily focus on medication...
(CVS) CVS Caremark Posts a Strong Quarter
CVS Caremark (CVS) reported third quarter 2011 EPS of 65 cents, 8.3% up year over year. However, after excluding the impact of certain one-time items, adjusted EPS came in at 70 cents, surpassing the Zacks...
(CVS) CVS Caremark Analyst Maintains Shares at Neutral
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $38.00.
CVS reported an adjusted EPS of 65 cents in the second quarter of 2011, surpassing...
(CVS) CVS Caremark Beats Earnings by a Penny – Guidance Narrowed
CVS Caremark (CVS) reported second quarter 2011 EPS of 60 cents, at par with the year-ago quarter earnings. However, after excluding the impact of certain one-time items, adjusted earnings per share came in...
(CVS) CVS Caremark Analyst Maintains Neutral on Shares
Recently, we reiterated our Neutral recommendation on CVS Caremark Corporation (CVS) with a target price of $41.00.
CVS Caremark reported an adjusted EPS of 57 cents in the first quarter of 2011, beating...
(MHS) Medco Analyst Maintains Shares at Neutral
Recently, we reiterated our Neutral recommendation on Medco Health (MHS) with a target price of $67.00.
Medco reported an adjusted EPS of 91 cents in the first quarter of fiscal 2011, beating both the...
(BAC) Stock Market News for Janurary 3, 2011 – Market News
Investors mostly stayed away from the Street on Friday, being New Year’s Eve and markets closed largely mixed. This was also one of the lightest volume trade days of the year. Though, apart from the Dow, certain benchmarks shed a few points on the closing day, the markets...
(UNH) Health Care Review and Outlook – September 2010 – Industry Outlook
The health care industry is currently undergoing a period of tremendous uncertainty due to the implications of the recent Health Care Reform Act — named the PPACA — after it becomes fully effective.
Why was the reform enacted?
- Health care costs,...
17Sep2010 | vitalstocks | 0 comments | Continued
(AIG) Insurance Industry Stock Update – August 2010 – Industry Outlook
After enduring stress with respect to pricing pressure and reduced insured exposure through mid-2009, the overall health of the U.S. insurance industry has improved to a great extent in 2010. Though the market turmoil forced many companies to take immense write-downs, the...
(AIG) Insurance Industry Stock Update – February 2010 – Industry Outlook
The turmoil in the financial markets has created a highly challenging environment for the U.S. insurance industry, forcing many companies to take immense write-downs. This trend is expected to continue at least through the first half of 2010, though there are some early signs...